Scarica l'app Stockscreener
29.08
2.25%
0.64
Dopo l'orario di chiusura:
29.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$28.44
Aprire:
$28.83
Volume 24 ore:
190.78K
Relative Volume:
1.43
Capitalizzazione di mercato:
$223.11M
Reddito:
-
Utile/perdita netta:
$-61.23M
Rapporto P/E:
-2.151
EPS:
-13.5194
Flusso di cassa netto:
$22.49M
1 W Prestazione:
+8.43%
1M Prestazione:
+41.51%
6M Prestazione:
+190.65%
1 anno Prestazione:
+65.32%
Intervallo 1D:
$28.34
$29.40
Intervallo di 1 settimana:
$25.72
$29.40
Portata 52W:
$7.75
$29.40
Assembly Biosciences Inc Stock (ASMB) Company Profile
Nome
Assembly Biosciences Inc
Settore
Industria
Telefono
(833) 409-4583
Indirizzo
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Confronta ASMB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
29.08 | 217.82M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-24 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-08-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-03-25 | Iniziato | Guggenheim | Buy |
| 2024-09-20 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-09-13 | Iniziato | H.C. Wainwright | Neutral |
| 2021-09-02 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | Downgrade | Jefferies | Buy → Hold |
| 2020-10-19 | Iniziato | Truist | Buy |
| 2019-10-16 | Iniziato | Mizuho | Buy |
| 2018-11-19 | Iniziato | Leerink Partners | Outperform |
| 2018-10-08 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | Iniziato | Robert W. Baird | Outperform |
| 2018-04-13 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | Iniziato | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | Iniziato | Jefferies | Buy |
| 2017-05-30 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Assembly Biosciences Inc Borsa (ASMB) Ultime notizie
Why Assembly Biosciences Inc. stock could rally in 2025Earnings Recap Summary & Short-Term High Return Strategies - newser.com
Does Assembly Biosciences Inc. show high probability of reboundMarket Weekly Review & Community Supported Trade Ideas - newser.com
Why retail investors favor Assembly Biosciences Inc. stockLong Setup & Technical Entry and Exit Alerts - newser.com
Assembly Biosciences (NASDAQ:ASMB) Given Buy Rating at HC Wainwright - Defense World
Will Assembly Biosciences Inc. (V7B) stock outperform small cap peers2025 Stock Rankings & Weekly Watchlist of Top Performers - newser.com
Assembly Biosciences stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com Canada
HC Wainwright & Co. Reiterates Assembly Biosciences (ASMB) Buy Recommendation - Nasdaq
Analyst Reiterates Buy Rating for ASMB with $50 Target | ASMB St - GuruFocus
Assembly Biosciences stock maintains Buy rating at H.C. Wainwright - Investing.com
Assembly Biosciences Announces Upcoming Investor Conference Participation - The Manila Times
Oct 21 on-demand chat & Nov 12 live fireside — Assembly Biosciences presents at two investor conferences - Stock Titan
Assembly Biosciences, Inc.'s (NASDAQ:ASMB) 27% Price Boost Is Out Of Tune With Revenues - 富途牛牛
Assembly Biosciences Gains 13%, Insider Trades Reap Benefit - simplywall.st
Real time social sentiment graph for Assembly Biosciences Inc.Earnings Beat & High Accuracy Swing Entry Alerts - newser.com
What consensus target says about Assembly Biosciences Inc. (V7B) stockQuarterly Market Summary & Daily Price Action Insights - newser.com
Will Assembly Biosciences Inc. benefit from macro trendsQuarterly Profit Report & Capital Efficiency Focused Strategies - newser.com
Will Assembly Biosciences Inc. (V7B) stock hit analyst forecastsEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
Does Assembly Biosciences Inc. qualify in momentum factor screening2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - newser.com
Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue Estimates - MSN
Assembly Biosciences (NASDAQ:ASMB) Shares Cross Above 200-Day Moving AverageTime to Sell? - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Shares Cross Above 200-Day Moving Average – Time to Sell? - Defense World
Assembly Bio reports positive interim data for genital herpes drug By Investing.com - Investing.com Nigeria
Assembly Biosciences Inc. stock chart pattern explainedQuarterly Profit Report & Risk Managed Investment Strategies - newser.com
Assembly Biosciences (ASMB) Reveals Promising Interim Data for H - GuruFocus
Assembly Bio reports positive interim data for genital herpes drug - Investing.com
Assembly Biosciences Presents Interim Phase 1b Data for HSV Helicase-Primase Inhibitor Candidate ABI-5366 at the 38th Congress of the International Union Against Sexually Transmitted Infections (IUSTI)- Europe - The Manila Times
94% HSV-2 shedding reduction — Assembly Bio's ABI-5366 (350 mg weekly) posts positive Phase 1b data - Stock Titan
Assembly Biosciences' (ASMB) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
What drives Assembly Biosciences Inc stock priceLong-Term Investment Plans & High Yield Investment Portfolio - earlytimes.in
Using economic indicators to assess Assembly Biosciences Inc. potentialWeekly Trade Analysis & Reliable Entry Point Alerts - newser.com
Will Assembly Biosciences Inc. (V7B) stock outperform benchmarksMarket Performance Report & AI Powered Buy and Sell Recommendations - newser.com
Why analysts upgrade Assembly Biosciences Inc. stock2025 Trading Volume Trends & AI Driven Stock Reports - newser.com
What MACD and RSI say about Assembly Biosciences Inc.Weekly Trade Review & Risk Managed Investment Entry Signals - newser.com
What momentum shifts mean for Assembly Biosciences Inc.Gold Moves & Expert Approved Trade Ideas - newser.com
What indicators show strength in Assembly Biosciences Inc.Weekly Earnings Recap & AI Based Buy/Sell Signal Reports - newser.com
Real time scanner hits for Assembly Biosciences Inc. explainedJuly 2025 Decliners & Fast Exit and Entry Strategy Plans - newser.com
How Assembly Biosciences Inc. (V7B) stock moves on employment dataJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com
Is Assembly Biosciences Inc. stock entering bullish territoryEarnings Growth Summary & Verified Stock Trade Ideas - newser.com
Will Assembly Biosciences Inc. (V7B) stock attract long term capital inflowsMarket Volume Summary & Short-Term Trading Opportunity Alerts - newser.com
Visualizing Assembly Biosciences Inc. stock with heatmaps2025 Market WrapUp & Expert Approved Trade Ideas - newser.com
Assembly Biosciences (NASDAQ:ASMB) Share Price Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
Assembly Biosciences Inc Azioni (ASMB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Assembly Biosciences Inc Azioni (ASMB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bjorkquist Jeanette M | Principal Accounting Officer |
Mar 31 '25 |
Sale |
9.85 |
180 |
1,773 |
4,617 |
| Okazaki Jason A | CEO and President |
Mar 31 '25 |
Sale |
9.85 |
355 |
3,496 |
14,757 |
| White Nicole S | Chief Manufacturing Officer |
Mar 31 '25 |
Sale |
9.85 |
197 |
1,940 |
11,674 |
| Houghton Michael | Director |
Dec 30 '24 |
Buy |
15.61 |
3,202 |
49,998 |
3,202 |
| GILEAD SCIENCES, INC. | 10% Owner |
Dec 19 '24 |
Buy |
21.37 |
940,499 |
20,098,464 |
2,209,471 |
| Schornstein Alexander | 10% Owner |
Nov 22 '24 |
Buy |
14.87 |
17,024 |
253,104 |
720,137 |
| Schornstein Alexander | 10% Owner |
Nov 25 '24 |
Buy |
14.91 |
7,976 |
118,890 |
728,113 |
| White Nicole S | Chief Manufacturing Officer |
Nov 18 '24 |
Sale |
16.29 |
40 |
652 |
11,871 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):